Clinical trial tech company Clario has sealed its second acquisition in a week, doubling down further on neuroscience by picking up imaging specialist NeuroRx.. NeuroRx founder and CEO Douglas ...

Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have acquired NeuroRx, a leader in imaging analysis with expertise in multiple sclerosis.

Health tech firm Clario is linking up with tech startup ArtiQ to leverage AI to fine-tune the collection of spirometry data in respiratory trials.. Together, the two companies will be able to ...

US-based clinical trial software company Clario has acquired WCG's electronic clinical outcome assessment (eCOA) business, having agreed to acquire it earlier this year. The acquisition aims to ...

Clario, a leading provider of digital endpoint data solutions to the clinical trial industry today announced completion of its acquisition of WCG's electronic clinical outcome assessment (eCOA ...

Tech firm Clario is boosting its electronic clinical outcome assessment (eCOA) offerings by acquiring the neuroscience-focused eCOA business of WCG. WCG's eCOA services provide specialized ...

Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in ...

Clario, a clinical health tech company, rolled out its latest offering—a cloud-based tool that allows sponsors and CROs to view medical images of their clinical trials as part of the company's ...

Clinical trial tech firm Clario has joined forces with CellCarta to improve the way tissue and other samples are handled during trials.. The collaboration will also encompass the digitization of ...

Clario, a provider of software to help drugmakers advance treatments through clinical trials, has filed confidentially for an initial public offering and is targeting a valuation of more than $10 ...